HEADER KINASE 13-MAY-15 4ZSG TITLE MITOGEN ACTIVATED PROTEIN KINASE 7 IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 7; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 47-393; COMPND 5 SYNONYM: MAPK 7,BIG MAP KINASE 1,BMK-1,EXTRACELLULAR SIGNAL-REGULATED COMPND 6 KINASE 5,ERK-5; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK7, BMK1, ERK5, PRKM7; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBAC HT A KEYWDS KINASE, INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR J.TUCKER,D.J.OGG REVDAT 3 01-MAY-24 4ZSG 1 REMARK REVDAT 2 11-MAY-16 4ZSG 1 JRNL REVDAT 1 04-MAY-16 4ZSG 0 JRNL AUTH H.CHEN,J.TUCKER,X.WANG,P.R.GAVINE,C.PHILLIPS,M.A.AUGUSTIN, JRNL AUTH 2 P.SCHREINER,S.STEINBACHER,M.PRESTON,D.OGG JRNL TITL DISCOVERY OF A NOVEL ALLOSTERIC INHIBITOR-BINDING SITE IN JRNL TITL 2 ERK5: COMPARISON WITH THE CANONICAL KINASE HINGE ATP-BINDING JRNL TITL 3 SITE. JRNL REF ACTA CRYSTALLOGR D STRUCT V. 72 682 2016 JRNL REF 2 BIOL JRNL REFN ISSN 2059-7983 JRNL PMID 27139631 JRNL DOI 10.1107/S2059798316004502 REMARK 2 REMARK 2 RESOLUTION. 1.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.79 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 43910 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM SELECTION REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2208 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.79 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.85 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.50 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3199 REMARK 3 BIN R VALUE (WORKING SET) : 0.2198 REMARK 3 BIN FREE R VALUE : 0.2276 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 144 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2772 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 344 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.39 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.28120 REMARK 3 B22 (A**2) : -2.28120 REMARK 3 B33 (A**2) : 4.56250 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.516 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.125 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.118 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.117 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.114 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: A 47 A 393 REMARK 3 ORIGIN FOR THE GROUP (A): 9.3624 -32.9683 -3.8049 REMARK 3 T TENSOR REMARK 3 T11: -0.0989 T22: -0.0542 REMARK 3 T33: -0.4225 T12: -0.1572 REMARK 3 T13: -0.0117 T23: -0.0986 REMARK 3 L TENSOR REMARK 3 L11: 1.5827 L22: 0.7605 REMARK 3 L33: 3.8830 L12: 0.1359 REMARK 3 L13: -0.6286 L23: 0.2173 REMARK 3 S TENSOR REMARK 3 S11: 0.2732 S12: -0.2400 S13: 0.1301 REMARK 3 S21: -0.2274 S22: 0.5983 S23: -0.0471 REMARK 3 S31: 0.1064 S32: -0.2261 S33: -0.0027 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4ZSG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-MAY-15. REMARK 100 THE DEPOSITION ID IS D_1000209806. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-NOV-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.25 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.972 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44410 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.790 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 10.60 REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.79 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 10.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: UNPUBLISHED IN-HOUSE ERK5/MAPK7 STRUCTURE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 4-6 % W/V PEG 6000, 0.1 M MES, 5 MM REMARK 280 DTT, PH 6.25, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.74000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 46.26500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 46.26500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 26.87000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 46.26500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 46.26500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 80.61000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 46.26500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 46.26500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 26.87000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 46.26500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 46.26500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 80.61000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 53.74000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1010 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 598 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 839 LIES ON A SPECIAL POSITION. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 50 CG OD1 OD2 REMARK 470 VAL A 51 CG1 CG2 REMARK 470 LEU A 76 CG CD1 CD2 REMARK 470 LYS A 110 CE NZ REMARK 470 THR A 124 OG1 CG2 REMARK 470 LYS A 265 CD CE NZ REMARK 470 GLN A 287 CG CD OE1 NE2 REMARK 470 ARG A 329 NE CZ NH1 NH2 REMARK 470 GLU A 393 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 76 -34.25 -179.71 REMARK 500 ARG A 181 -3.93 75.44 REMARK 500 ASP A 200 79.93 58.37 REMARK 500 ALA A 223 -149.23 73.61 REMARK 500 ALA A 291 110.38 -170.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 831 DISTANCE = 6.12 ANGSTROMS REMARK 525 HOH A 832 DISTANCE = 6.15 ANGSTROMS REMARK 525 HOH A 833 DISTANCE = 6.25 ANGSTROMS REMARK 525 HOH A 834 DISTANCE = 6.46 ANGSTROMS REMARK 525 HOH A 835 DISTANCE = 6.64 ANGSTROMS REMARK 525 HOH A 836 DISTANCE = 6.65 ANGSTROMS REMARK 525 HOH A 837 DISTANCE = 7.01 ANGSTROMS REMARK 525 HOH A 838 DISTANCE = 8.49 ANGSTROMS REMARK 525 HOH A 839 DISTANCE = 8.49 ANGSTROMS REMARK 525 HOH A 840 DISTANCE = 8.69 ANGSTROMS REMARK 525 HOH A 841 DISTANCE = 9.01 ANGSTROMS REMARK 525 HOH A 842 DISTANCE = 9.54 ANGSTROMS REMARK 525 HOH A 843 DISTANCE = 10.07 ANGSTROMS REMARK 525 HOH A 844 DISTANCE = 12.67 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4QX A 406 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4B99 RELATED DB: PDB REMARK 900 SAME PROTEIN DBREF 4ZSG A 47 393 UNP Q13164 MK07_HUMAN 47 393 SEQRES 1 A 347 VAL THR PHE ASP VAL GLY ASP GLU TYR GLU ILE ILE GLU SEQRES 2 A 347 THR ILE GLY ASN GLY ALA TYR GLY VAL VAL SER SER ALA SEQRES 3 A 347 ARG ARG ARG LEU THR GLY GLN GLN VAL ALA ILE LYS LYS SEQRES 4 A 347 ILE PRO ASN ALA PHE ASP VAL VAL THR ASN ALA LYS ARG SEQRES 5 A 347 THR LEU ARG GLU LEU LYS ILE LEU LYS HIS PHE LYS HIS SEQRES 6 A 347 ASP ASN ILE ILE ALA ILE LYS ASP ILE LEU ARG PRO THR SEQRES 7 A 347 VAL PRO TYR GLY GLU PHE LYS SER VAL TYR VAL VAL LEU SEQRES 8 A 347 ASP LEU MET GLU SER ASP LEU HIS GLN ILE ILE HIS SER SEQRES 9 A 347 SER GLN PRO LEU THR LEU GLU HIS VAL ARG TYR PHE LEU SEQRES 10 A 347 TYR GLN LEU LEU ARG GLY LEU LYS TYR MET HIS SER ALA SEQRES 11 A 347 GLN VAL ILE HIS ARG ASP LEU LYS PRO SER ASN LEU LEU SEQRES 12 A 347 VAL ASN GLU ASN CYS GLU LEU LYS ILE GLY ASP PHE GLY SEQRES 13 A 347 MET ALA ARG GLY LEU CYS THR SER PRO ALA GLU HIS GLN SEQRES 14 A 347 TYR PHE MET THR GLU TYR VAL ALA THR ARG TRP TYR ARG SEQRES 15 A 347 ALA PRO GLU LEU MET LEU SER LEU HIS GLU TYR THR GLN SEQRES 16 A 347 ALA ILE ASP LEU TRP SER VAL GLY CYS ILE PHE GLY GLU SEQRES 17 A 347 MET LEU ALA ARG ARG GLN LEU PHE PRO GLY LYS ASN TYR SEQRES 18 A 347 VAL HIS GLN LEU GLN LEU ILE MET MET VAL LEU GLY THR SEQRES 19 A 347 PRO SER PRO ALA VAL ILE GLN ALA VAL GLY ALA GLU ARG SEQRES 20 A 347 VAL ARG ALA TYR ILE GLN SER LEU PRO PRO ARG GLN PRO SEQRES 21 A 347 VAL PRO TRP GLU THR VAL TYR PRO GLY ALA ASP ARG GLN SEQRES 22 A 347 ALA LEU SER LEU LEU GLY ARG MET LEU ARG PHE GLU PRO SEQRES 23 A 347 SER ALA ARG ILE SER ALA ALA ALA ALA LEU ARG HIS PRO SEQRES 24 A 347 PHE LEU ALA LYS TYR HIS ASP PRO ASP ASP GLU PRO ASP SEQRES 25 A 347 CYS ALA PRO PRO PHE ASP PHE ALA PHE ASP ARG GLU ALA SEQRES 26 A 347 LEU THR ARG GLU ARG ILE LYS GLU ALA ILE VAL ALA GLU SEQRES 27 A 347 ILE GLU ASP PHE HIS ALA ARG ARG GLU HET GOL A 401 6 HET GOL A 402 6 HET GOL A 403 6 HET GOL A 404 6 HET GOL A 405 6 HET 4QX A 406 35 HETNAM GOL GLYCEROL HETNAM 4QX 3-AMINO-5-[(4-CHLOROPHENYL)AMINO]-N-(PROPAN-2-YL)-1H-1, HETNAM 2 4QX 2,4-TRIAZOLE-1-CARBOXAMIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 GOL 5(C3 H8 O3) FORMUL 7 4QX C12 H15 CL N6 O FORMUL 8 HOH *344(H2 O) HELIX 1 AA1 VAL A 92 PHE A 109 1 18 HELIX 2 AA2 PRO A 126 PHE A 130 5 5 HELIX 3 AA3 LEU A 144 HIS A 149 1 6 HELIX 4 AA4 THR A 155 ALA A 176 1 22 HELIX 5 AA5 LYS A 184 SER A 186 5 3 HELIX 6 AA6 GLU A 213 PHE A 217 5 5 HELIX 7 AA7 MET A 218 VAL A 222 5 5 HELIX 8 AA8 THR A 224 ARG A 228 5 5 HELIX 9 AA9 ALA A 229 SER A 235 1 7 HELIX 10 AB1 GLN A 241 ARG A 258 1 18 HELIX 11 AB2 ASN A 266 GLY A 279 1 14 HELIX 12 AB3 SER A 282 ALA A 288 1 7 HELIX 13 AB4 ALA A 291 GLN A 299 1 9 HELIX 14 AB5 PRO A 308 TYR A 313 1 6 HELIX 15 AB6 ASP A 317 LEU A 328 1 12 HELIX 16 AB7 GLU A 331 ARG A 335 5 5 HELIX 17 AB8 SER A 337 ARG A 343 1 7 HELIX 18 AB9 HIS A 344 ALA A 348 5 5 HELIX 19 AC1 ASP A 352 GLU A 356 5 5 HELIX 20 AC2 PHE A 365 GLU A 370 1 6 HELIX 21 AC3 THR A 373 GLU A 393 1 21 SHEET 1 AA1 5 TYR A 55 ILE A 61 0 SHEET 2 AA1 5 VAL A 69 ARG A 74 -1 O SER A 71 N GLU A 59 SHEET 3 AA1 5 GLN A 80 ILE A 86 -1 O VAL A 81 N ALA A 72 SHEET 4 AA1 5 VAL A 133 LEU A 137 -1 O VAL A 133 N ILE A 86 SHEET 5 AA1 5 ILE A 117 ILE A 120 -1 N ASP A 119 O VAL A 136 SHEET 1 AA2 3 SER A 142 ASP A 143 0 SHEET 2 AA2 3 LEU A 188 VAL A 190 -1 O VAL A 190 N SER A 142 SHEET 3 AA2 3 LEU A 196 ILE A 198 -1 O LYS A 197 N LEU A 189 CISPEP 1 ALA A 360 PRO A 361 0 2.91 SITE 1 AC1 6 PRO A 153 LEU A 154 THR A 155 ARG A 258 SITE 2 AC1 6 GLY A 290 ALA A 291 SITE 1 AC2 6 GLU A 192 GLU A 220 ARG A 225 ARG A 228 SITE 2 AC2 6 MET A 233 TYR A 267 SITE 1 AC3 3 HIS A 108 TYR A 172 ALA A 360 SITE 1 AC4 5 PHE A 90 ASP A 91 ARG A 374 GLU A 375 SITE 2 AC4 5 HOH A 516 SITE 1 AC5 4 GLU A 192 THR A 224 ARG A 225 TRP A 226 SITE 1 AC6 11 TYR A 66 LYS A 84 ILE A 86 ASN A 95 SITE 2 AC6 11 ARG A 98 THR A 99 GLU A 102 LEU A 103 SITE 3 AC6 11 ILE A 117 VAL A 135 HOH A 724 CRYST1 92.530 92.530 107.480 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010807 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010807 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009304 0.00000